Neoadjuvant hormonal therapy promising in high-risk prostate cancer Presented ByProf. Steven Joniau, UZ Leuven, Belgium TrialPhase 2, ARNEO ConferenceEAU 2022 22 July, 2022 12:35
Good tolerance of post-RP radiotherapy ± short-term ADT Presented ByDr Paul Sargos , Institut Bergonié, France TrialPhase 2, GETUG-AFU 22 ConferenceEAU 2020 20 August, 2020 12:54
